Erythropoietin (EPO) Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Erythropoietin (EPO) Drugs Market to 2027 - Global Analysis and Forecasts by

Report Code: TIPRE00004608 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Erythropoietin is a hormone which is basically produced by the kidneys helping in production of red blood cells, which carry oxygen from the lungs to rest of the body. Erythropoietin drugs are injectable drugs used to cure anemia and other such diseases.

MARKET DYNAMICS
The Erythropoietin (EPO) Drugs market is anticipated to grow in the forecast period owing to driving factors such as rising number of patients suffering from anemia, favorable reimbursements and increasing commercialization of EPO biosimilars and rising incidence of Chronic Kidney Diseases.

MARKET SCOPE
The "Global Erythropoietin (EPO) Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Erythropoietin (EPO) Drugs market with detailed market segmentation by Drug, Product, Application and geography. The global Erythropoietin (EPO) Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Erythropoietin (EPO) Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Erythropoietin (EPO) Drugs market is segmented on the basis of Drug, Product and Application. Based on Drugs the market is segmented into Biologics, Biosimilars. Based on Product the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa. Based on Application the market is segmented into Cancer, Hematology, Renal Disease, Neurology.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Erythropoietin (EPO) Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Erythropoietin (EPO) Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Erythropoietin (EPO) Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Erythropoietin (EPO) Drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the Erythropoietin (EPO) Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Erythropoietin (EPO) Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Erythropoietin (EPO) Drugs in the global market. Below mentioned is the list of few companies engaged in the Erythropoietin (EPO) Drugs market.

The report also includes the profiles of key Erythropoietin (EPO) Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Johnson & Johnson
  • Celltrion, Inc
  • Teva Pharmaceutical Industries Ltd
  • Amgen, Inc
  • F. Hoffman-La Roche Ltd.
  • LG Life Sciences Ltd.
  • Biocon Limited
  • Intas Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Erythropoietin (EPO) Drugs Market - By Drug
1.3.2 Erythropoietin (EPO) Drugs Market - By Product
1.3.3 Erythropoietin (EPO) Drugs Market - By Application
1.3.4 Erythropoietin (EPO) Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ERYTHROPOIETIN (EPO) DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ERYTHROPOIETIN (EPO) DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ERYTHROPOIETIN (EPO) DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ERYTHROPOIETIN (EPO) DRUGS - GLOBAL MARKET OVERVIEW
6.2. ERYTHROPOIETIN (EPO) DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. BIOLOGICS
7.3.1. Overview
7.3.2. Biologics Market Forecast and Analysis
7.4. BIOSIMILARS
7.4.1. Overview
7.4.2. Biosimilars Market Forecast and Analysis
8. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. EPOETIN-ALFA
8.3.1. Overview
8.3.2. Epoetin-alfa Market Forecast and Analysis
8.4. EPOETIN-BETA
8.4.1. Overview
8.4.2. Epoetin-beta Market Forecast and Analysis
8.5. DARBEPOETIN-ALFA
8.5.1. Overview
8.5.2. Darbepoetin-alfa Market Forecast and Analysis
9. ERYTHROPOIETIN (EPO) DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CANCER
9.3.1. Overview
9.3.2. Cancer Market Forecast and Analysis
9.4. HEMATOLOGY
9.4.1. Overview
9.4.2. Hematology Market Forecast and Analysis
9.5. RENAL DISEASE
9.5.1. Overview
9.5.2. Renal Disease Market Forecast and Analysis
9.6. NEUROLOGY
9.6.1. Overview
9.6.2. Neurology Market Forecast and Analysis
10. ERYTHROPOIETIN (EPO) DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Erythropoietin (EPO) Drugs Market Overview
10.1.2 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis
10.1.3 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug
10.1.4 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product
10.1.5 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application
10.1.6 North America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Erythropoietin (EPO) Drugs Market
10.1.6.1.1 United States Erythropoietin (EPO) Drugs Market by Drug
10.1.6.1.2 United States Erythropoietin (EPO) Drugs Market by Product
10.1.6.1.3 United States Erythropoietin (EPO) Drugs Market by Application
10.1.6.2 Canada Erythropoietin (EPO) Drugs Market
10.1.6.2.1 Canada Erythropoietin (EPO) Drugs Market by Drug
10.1.6.2.2 Canada Erythropoietin (EPO) Drugs Market by Product
10.1.6.2.3 Canada Erythropoietin (EPO) Drugs Market by Application
10.1.6.3 Mexico Erythropoietin (EPO) Drugs Market
10.1.6.3.1 Mexico Erythropoietin (EPO) Drugs Market by Drug
10.1.6.3.2 Mexico Erythropoietin (EPO) Drugs Market by Product
10.1.6.3.3 Mexico Erythropoietin (EPO) Drugs Market by Application
10.1.6.4 US Erythropoietin (EPO) Drugs Market
10.1.6.4.1 US Erythropoietin (EPO) Drugs Market by Drug
10.1.6.4.2 US Erythropoietin (EPO) Drugs Market by Product
10.1.6.4.3 US Erythropoietin (EPO) Drugs Market by Application
10.2. EUROPE
10.2.1 Europe Erythropoietin (EPO) Drugs Market Overview
10.2.2 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis
10.2.3 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug
10.2.4 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product
10.2.5 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application
10.2.6 Europe Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Erythropoietin (EPO) Drugs Market
10.2.6.1.1 Germany Erythropoietin (EPO) Drugs Market by Drug
10.2.6.1.2 Germany Erythropoietin (EPO) Drugs Market by Product
10.2.6.1.3 Germany Erythropoietin (EPO) Drugs Market by Application
10.2.6.2 France Erythropoietin (EPO) Drugs Market
10.2.6.2.1 France Erythropoietin (EPO) Drugs Market by Drug
10.2.6.2.2 France Erythropoietin (EPO) Drugs Market by Product
10.2.6.2.3 France Erythropoietin (EPO) Drugs Market by Application
10.2.6.3 Italy Erythropoietin (EPO) Drugs Market
10.2.6.3.1 Italy Erythropoietin (EPO) Drugs Market by Drug
10.2.6.3.2 Italy Erythropoietin (EPO) Drugs Market by Product
10.2.6.3.3 Italy Erythropoietin (EPO) Drugs Market by Application
10.2.6.4 Spain Erythropoietin (EPO) Drugs Market
10.2.6.4.1 Spain Erythropoietin (EPO) Drugs Market by Drug
10.2.6.4.2 Spain Erythropoietin (EPO) Drugs Market by Product
10.2.6.4.3 Spain Erythropoietin (EPO) Drugs Market by Application
10.2.6.5 United Kingdom Erythropoietin (EPO) Drugs Market
10.2.6.5.1 United Kingdom Erythropoietin (EPO) Drugs Market by Drug
10.2.6.5.2 United Kingdom Erythropoietin (EPO) Drugs Market by Product
10.2.6.5.3 United Kingdom Erythropoietin (EPO) Drugs Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Erythropoietin (EPO) Drugs Market Overview
10.3.2 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug
10.3.4 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product
10.3.5 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Erythropoietin (EPO) Drugs Market
10.3.6.1.1 Australia Erythropoietin (EPO) Drugs Market by Drug
10.3.6.1.2 Australia Erythropoietin (EPO) Drugs Market by Product
10.3.6.1.3 Australia Erythropoietin (EPO) Drugs Market by Application
10.3.6.2 China Erythropoietin (EPO) Drugs Market
10.3.6.2.1 China Erythropoietin (EPO) Drugs Market by Drug
10.3.6.2.2 China Erythropoietin (EPO) Drugs Market by Product
10.3.6.2.3 China Erythropoietin (EPO) Drugs Market by Application
10.3.6.3 India Erythropoietin (EPO) Drugs Market
10.3.6.3.1 India Erythropoietin (EPO) Drugs Market by Drug
10.3.6.3.2 India Erythropoietin (EPO) Drugs Market by Product
10.3.6.3.3 India Erythropoietin (EPO) Drugs Market by Application
10.3.6.4 Japan Erythropoietin (EPO) Drugs Market
10.3.6.4.1 Japan Erythropoietin (EPO) Drugs Market by Drug
10.3.6.4.2 Japan Erythropoietin (EPO) Drugs Market by Product
10.3.6.4.3 Japan Erythropoietin (EPO) Drugs Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Erythropoietin (EPO) Drugs Market Overview
10.4.2 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug
10.4.4 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product
10.4.5 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Erythropoietin (EPO) Drugs Market
10.4.6.1.1 South Africa Erythropoietin (EPO) Drugs Market by Drug
10.4.6.1.2 South Africa Erythropoietin (EPO) Drugs Market by Product
10.4.6.1.3 South Africa Erythropoietin (EPO) Drugs Market by Application
10.4.6.2 Saudi Arabia Erythropoietin (EPO) Drugs Market
10.4.6.2.1 Saudi Arabia Erythropoietin (EPO) Drugs Market by Drug
10.4.6.2.2 Saudi Arabia Erythropoietin (EPO) Drugs Market by Product
10.4.6.2.3 Saudi Arabia Erythropoietin (EPO) Drugs Market by Application
10.4.6.3 U.A.E Erythropoietin (EPO) Drugs Market
10.4.6.3.1 U.A.E Erythropoietin (EPO) Drugs Market by Drug
10.4.6.3.2 U.A.E Erythropoietin (EPO) Drugs Market by Product
10.4.6.3.3 U.A.E Erythropoietin (EPO) Drugs Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Erythropoietin (EPO) Drugs Market Overview
10.5.2 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis
10.5.3 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Drug
10.5.4 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Product
10.5.5 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Application
10.5.6 South and Central America Erythropoietin (EPO) Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Erythropoietin (EPO) Drugs Market
10.5.6.1.1 Brazil Erythropoietin (EPO) Drugs Market by Drug
10.5.6.1.2 Brazil Erythropoietin (EPO) Drugs Market by Product
10.5.6.1.3 Brazil Erythropoietin (EPO) Drugs Market by Application
10.5.6.2 Argentina Erythropoietin (EPO) Drugs Market
10.5.6.2.1 Argentina Erythropoietin (EPO) Drugs Market by Drug
10.5.6.2.2 Argentina Erythropoietin (EPO) Drugs Market by Product
10.5.6.2.3 Argentina Erythropoietin (EPO) Drugs Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ERYTHROPOIETIN (EPO) DRUGS MARKET, KEY COMPANY PROFILES
12.1. JOHNSON AND JOHNSON
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELLTRION, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMGEN, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMAN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LG LIFE SCIENCES LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOCON LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INTAS PHARMACEUTICALS LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUN PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DR. REDDY’S LABORATORIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies


- Johnson & Johnson
- Celltrion, Inc
- Teva Pharmaceutical Industries Ltd
- Amgen, Inc
- F. Hoffman-La Roche Ltd.
- LG Life Sciences Ltd.
- Biocon Limited
- Intas Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book